Cancer is as natural as the multicellular life it afflicts. Far from being a modern invention or a product of industrial civilization, cancer has existed for hundreds of millions of years and has been found in organisms ranging from ancient dinosaurs to simple freshwater polyps with no organs or blood. The disease arises from biological processes baked into the very architecture of complex life, and understanding why requires looking at cancer not as an outside invader but as an inherent vulnerability of any body made of cooperating cells.
Why Multicellularity Makes Cancer Inevitable
Every animal, plant, and fungus that consists of more than one cell faces a fundamental problem: those cells have to cooperate. They need to divide only when told to, die when they are supposed to, share resources fairly, and stay where they belong. When any one cell breaks those rules and starts proliferating on its own terms, the result is a tumor. Evolutionary biologists describe cancer as a breakdown of the cooperation that holds a multicellular body together, a kind of revolt at the cellular level where natural selection favors the rogue cell over the collective organism.1PubMed Central. Cancer and Inter-Cellular Cooperation
Multicellularity evolved independently many times across the tree of life, and in every case it required cells to give up some of their individual autonomy. Researchers have identified several foundations of cellular cooperation that all complex multicellular lineages depend on: cells must inhibit their own proliferation when appropriate, undergo controlled death when damaged, allocate resources to the group, specialize into different types, maintain the shared environment between cells, and stay in their proper location.2Evolution, Medicine, and Public Health. Multicellular cooperation and the hallmarks of cancer: A new foundation Cancer, at its most basic, is what happens when one or more of these cooperative foundations collapses in a cell lineage. The cell stops listening to signals that tell it to stop growing, evades the self-destruct programs that would normally eliminate it, and begins consuming resources meant for its neighbors. This is not a malfunction imported from the outside. It is a failure mode built into the system.
Cancer in Deep Time
If cancer were a modern disease, you would not expect to find it in the fossil record. But it is there, and it stretches back far further than human civilization. A confirmed case of advanced bone cancer was diagnosed in a Centrosaurus apertus, a horned dinosaur that lived during the Cretaceous period, tens of millions of years ago. Researchers used CT scans and tissue analysis to identify the tumor as osteosarcoma, the same aggressive bone cancer that occurs in humans today.3PubMed Central. CT and Histopathology Used to Diagnose Osteosarcoma in a Dinosaur This was not a case of ambiguous pathology. The tumor had progressed to an advanced stage, meaning the animal likely lived with the disease for some time before dying.
Even more striking is the discovery of tumors in Hydra, a genus of tiny freshwater animals that diverged from the lineage leading to humans over half a billion years ago. Hydra are about as simple as an animal can get: two cell layers, no organs, no circulatory system. Yet multiple species of Hydra develop spontaneous tumors with visible nodules and tissue enlargement.4PubMed Central. Spontaneously occurring tumors in different wild-derived strains of hydra These tumors are transplantable between individual polyps, reduce the animal’s fitness, and show gene expression changes that closely mirror those seen in vertebrate cancers.5Nature Communications. Naturally occurring tumours in the basal metazoan Hydra The fact that an organism this ancient and this simple can develop tumors tells us something profound: the vulnerability to cancer is not a recent evolutionary accident. It emerged alongside multicellularity itself and has persisted ever since.
The Body Size Puzzle
If cancer is simply a matter of cells going rogue, you might expect that the more cells an organism has, the more cancer it should get. A blue whale has trillions more cells than a mouse, and each of those cells undergoes division, so the raw number of opportunities for something to go wrong is vastly greater. Yet whales do not seem to get cancer at rates that reflect their enormous cell count. This disconnect between body size and cancer risk is known as Peto’s paradox, and it has puzzled biologists for decades.6PubMed Central. Peto’s Paradox: evolution’s prescription for cancer prevention
Animals with a thousand times more cells than humans do not show increased cancer risk, which implies that natural mechanisms can suppress cancer far more effectively than is done in human cells.7Trends in Ecology & Evolution. Is Cancer Natural? A Biological Perspective on Its Origins The implication is that as lineages evolved larger bodies over millions of years, they simultaneously evolved stronger cancer-suppression machinery. The most dramatic example comes from elephants. The elephant genome contains roughly 20 copies of the tumor suppressor gene TP53, compared to just one copy in humans.8PubMed Central. TP53 copy number expansion is associated with the evolution of increased body size and an enhanced DNA damage response in elephants This expansion in TP53 copies occurred alongside the evolution of large body size in the elephant lineage and is linked to a heightened sensitivity to DNA damage: elephant cells are more likely to self-destruct in response to genetic errors rather than attempt to repair and carry on.9PubMed Central. Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans
Peto’s paradox underscores that cancer suppression is not a static feature of biology but an evolving one. Evolution can and does build better defenses against cancer when the selective pressure is strong enough. The flip side is that species like humans, which evolved relatively small bodies, did not face the same pressure to pile on extra tumor-suppressor copies. Our cancer defenses are good enough for a small-to-medium primate, but they are not anywhere close to what a whale or an elephant has evolved.
How the Immune System Acts as a Tumor Suppressor
Beyond genes like TP53, the body has another line of defense: the immune system. The idea that immune cells patrol the body for nascent tumors was debated for decades, but evidence from both animal models and human studies now supports it. Certain immune cell types, signaling molecules, and immune pathways collectively function as an external tumor-suppression system, identifying and destroying abnormal cells before they can grow into detectable tumors.10PubMed Central. Immune surveillance of tumors
This immune surveillance is imperfect. Cancer cells that eventually form tumors are, almost by definition, the ones that managed to evade immune detection, either by disguising themselves or by actively suppressing the immune response in their immediate neighborhood. The tug-of-war between immune cells and rogue cells is constant, and it is happening inside every one of us. Most of the time, the immune system wins and we never know a pre-cancerous cell existed. When it loses, a tumor forms. This dynamic means that anything that weakens the immune system, whether aging, chronic infection, immunosuppressive drugs, or stress, tilts the balance toward cancer. It also helps explain why cancer rates rise sharply in older adults, whose immune surveillance gradually deteriorates.
Mutations That Come from Within
A common misconception is that cancer requires some external cause: a toxic chemical, radiation, a virus. Those things certainly increase the risk, but a large share of cancer-driving mutations arise from the body’s own internal processes. Every time a cell divides, it copies about three billion base pairs of DNA, and despite sophisticated proofreading systems, errors slip through. Damage also accumulates from normal metabolic processes like energy production and gene transcription, which generate reactive molecules capable of altering DNA. Even in cells with fully functional repair pathways, the sheer volume of ongoing damage from these internal processes can occasionally overwhelm the repair machinery.11PubMed Central. Endogenous DNA Damage as a Source of Genomic Instability in Cancer
This matters because it means that even in a perfectly clean environment with zero exposure to pollution, radiation, or carcinogens, cancer would still occur. The rate would be lower for certain cancer types, but the baseline risk created by internal mutation would not disappear. The body generates its own mutagenic stress simply by being alive and maintaining its tissues. This is one of the most important reasons cancer is natural: it is not solely or even primarily an environmental disease, but a consequence of the thermodynamic and biochemical realities of maintaining a complex organism over time.
Natural Carcinogens Predate Industry
That said, the natural environment is not benign. Long before factories or synthetic chemicals existed, organisms were exposed to cancer-promoting agents that are entirely natural in origin. Ultraviolet radiation from the sun is the major cause of skin cancers, including both common non-melanoma types and melanoma.12PubMed Central. Environmental Factors Inducing Human Cancers Radon, a radioactive gas that seeps naturally from soil and rock, increases lung cancer risk. And aflatoxins, produced by Aspergillus fungi that grow on grains and nuts, are potent carcinogens that cause mutations in the p53 gene, one of the body’s most important tumor suppressors.12PubMed Central. Environmental Factors Inducing Human Cancers Populations in tropical regions with high dietary aflatoxin exposure have historically experienced elevated rates of liver cancer, a pattern that existed for millennia before anyone understood why.
Ionizing radiation from cosmic rays has bombarded every living thing on Earth since life began. Volcanic eruptions release carcinogenic compounds. Certain plant alkaloids are mutagenic. The distinction between “natural” and “man-made” carcinogens is meaningful for regulation and risk management, but from a biological standpoint, a mutation caused by sunlight and a mutation caused by an industrial chemical look the same to a cell. Both alter DNA in ways that can, over time, lead to cancer.
Cancer in Ancient Humans
Archaeological evidence confirms that cancer predates modernity by thousands of years. The earliest known complete example of metastatic cancer in a human comes from the archaeological site of Amara West in northern Sudan, dating to around 1200 BC. The skeleton belonged to a young adult male whose vertebrae, ribs, sternum, clavicles, pelvis, and other bones showed extensive destructive lesions consistent with cancer that had spread from a soft-tissue tumor to the skeleton.13PubMed Central. On the antiquity of cancer: evidence for metastatic carcinoma in a young man from ancient Nubia (c. 1200 BC) This was not an elderly individual whose cancer could be attributed to a long life; it was a young man in an ancient Nubian community, well before any exposure to modern industrial pollutants.
Studies of Egyptian mummies have also turned up evidence of malignancy. A systematic assessment using CT imaging on 45 mummified individuals found probable malignant skeletal disease in about 2% of cases and probable malignant soft-tissue masses in roughly 11%.14Scientific Reports. Systematic assessment of bone and soft tissue tumors on whole-body CTs of 45 mummies from ancient Egypt These rates are likely underestimates, since soft tissues preserve poorly over millennia and many cancers leave no mark on bone. The argument that cancer is “a disease of civilization” falls apart in the face of this evidence. Cancer was rarer in antiquity because most people died young from infection, violence, or malnutrition before they could develop it, not because the biological potential for cancer did not exist.
Cancers That Spread Between Animals
One of the strangest chapters in cancer biology involves transmissible cancers, tumors that can pass from one individual to another like an infection. These are not virus-caused cancers; the cancer cells themselves are the infectious agent, physically transferring between hosts. Transmissible cancers have been identified in four unrelated groups of animals: dogs, Tasmanian devils, Syrian hamsters, and marine bivalves like clams and mussels.15PubMed Central. What Animal Cancers teach us about Human Biology
The most devastating example is devil facial tumor disease, which encompasses two independent transmissible cancers that have killed the majority of Tasmanian devils in the wild. The cancer cells originated from a type of nerve-sheath cell and spread between devils during biting, which is common during mating season.16PubMed Central. A Devil of a Transmissible Cancer The fact that transmissible cancers arose independently in such distantly related species suggests that this phenomenon, while rare, is another natural consequence of the biology of cancer cells. A sufficiently aggressive cancer, in a host population with low enough genetic diversity to prevent immune rejection, can essentially become a parasitic organism unto itself.
Aging and the Accumulation of Driver Mutations
One of the most powerful predictors of cancer in humans is simply getting older. This is not just because the immune system weakens with age. It is also because somatic cells quietly accumulate mutations throughout a person’s life, and some of those mutations land in genes that drive cancer. Recent studies have revealed that normal, healthy tissues in older adults harbor surprisingly large numbers of cells carrying cancer-associated mutations. These mutant clones expand over time, creating patches of tissue that look normal under a microscope but carry the genetic seeds of potential malignancy.17PubMed Central. Aging and the rise of somatic cancer-associated mutations in normal tissues
This phenomenon means that by middle age, virtually every person carries cells with at least some cancer-driver mutations, even if they never develop a detectable tumor. The progression from a normal cell to a cancer cell typically requires multiple such mutations accumulating in the same cell lineage over years or decades. Each mutation is individually unlikely to cause harm, but the longer you live, the more dice rolls occur. Cancer in old age is, in a real sense, the price of a long life. Evolution has invested heavily in keeping us cancer-free through our reproductive years, when survival matters most for passing on genes. After that, the selective pressure to suppress cancer drops off considerably.
Evolutionary Trade-Offs and Why Cancer Persists
If cancer is so harmful, why hasn’t evolution eliminated it? Part of the answer is the mutation-accumulation story above, but there is a deeper reason. Many of the biological pathways that promote cancer also serve essential functions earlier in life. Rapid cell proliferation is critical for wound healing, immune responses, and growth. Genes that drive aggressive cell division in a developing embryo can, decades later, fuel tumor growth when reactivated by a mutation. This phenomenon, where a gene or variant that helps early in life causes harm later, provides strong support for the idea that evolution has effectively traded improved fitness in youth for a higher burden of disease in old age.18PubMed. Antagonistic Pleiotropy in Human Disease
Evolution cannot easily eliminate cancer susceptibility without also dismantling the cell growth and repair systems that keep organisms alive and functional. This is why cancer is not just natural but, in a sense, inevitable for any sufficiently complex, long-lived multicellular organism. The machinery that makes us viable, that heals our wounds and builds our tissues, is the same machinery that can, under the wrong circumstances, turn against us.
Somatic Evolution Within a Single Body
Cancer progression follows Darwinian principles, but on a miniature scale inside the body. Once a cell acquires a mutation that gives it a growth advantage, it can outcompete its neighbors and produce a cluster of daughter cells that share that mutation. If one of those daughter cells picks up a second advantageous mutation, it gains a further edge. Over time, the most aggressive lineage wins out, in exactly the way natural selection works in ecosystems. Tumor progression has been described as a neo-Darwinian evolution within the tissue, where random genetic mutations create malignant cell types that are selected based on how well they grow in the local environment.19PubMed. Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution
This somatic evolution is why cancer is so difficult to treat. By the time a tumor is detected, it often contains multiple genetically distinct subpopulations, each adapted to slightly different conditions. A treatment that kills 99% of the tumor may leave behind the 1% that happens to be resistant, and that resistant clone then repopulates. The tumor evolves in response to therapy the same way a bacterial population evolves resistance to antibiotics. This is not a design flaw in treatment. It is a fundamental feature of how life works at the cellular level.
Epigenetic Changes and Cancer Without New Mutations
Not all cancer-promoting changes involve alterations to the DNA sequence itself. Cells also regulate gene activity through chemical modifications that sit on top of the genome, controlling which genes are turned on or off in a given cell type. These modifications can be disrupted by genetic errors, environmental exposures, or metabolic changes, leading to states where genes that should be silent become active, or protective genes get shut down. Such epigenetic changes are present in all human cancers and cooperate with genetic mutations to drive the disease.20PubMed Central. Epigenetic Determinants of Cancer
What makes epigenetic disruption particularly interesting is that it can happen without any mutation at all. A cell whose gene-regulation landscape becomes too loose or too rigid can stumble into a cancerous state through stochastic changes, random fluctuations in gene expression that occasionally activate a growth-promoting gene or silence a tumor suppressor. Most of these random events have no consequences, but some confer a fitness advantage to the cell and get selected for, functioning as “driver” events in tumor development.21PubMed Central. Epigenetic plasticity and the hallmarks of cancer The interplay between genetics and epigenetics means that cancer has more avenues to develop than mutations alone would suggest, adding yet another layer to why it is so deeply woven into the fabric of multicellular biology.
When Human Activity Shifts the Balance in Wildlife
While cancer is undeniably natural, human activity can dramatically shift the baseline risk for wild animal populations. One well-documented case involves beluga whales in the St. Lawrence Estuary in Quebec, Canada. These whales developed cancer at rates far exceeding those seen in other beluga populations, and the pattern of cancers they developed resembled those found in human communities living along the same heavily contaminated waterway. Researchers concluded that the whales and the local human population were likely affected by the same environmental contaminants in their shared habitat.22PubMed Central. Cancer in wildlife, a case study: beluga from the St. Lawrence estuary, Québec, Canada
Cases like these illustrate an important nuance. Cancer does not need human help to exist, but pollutants, habitat destruction, and other anthropogenic stressors can turn a manageable background risk into a population-level crisis. The natural defenses that organisms have evolved against cancer are calibrated to the mutational load of a normal environment. When that load increases dramatically because of chemical contamination or other factors, those defenses can be overwhelmed. Wild animals exposed to industrial runoff, nuclear fallout, or agricultural chemicals serve as sentinels, their cancer rates telling us something about the risks present in environments we share with them.
Pathogens and Cancer Through Evolutionary History
Some of the oldest relationships between cancer and the natural world involve pathogens. Certain viruses, bacteria, and parasites have evolved strategies that, as a side effect or direct consequence of their life cycles, promote cancer in their hosts. Human papillomavirus and cervical cancer, Helicobacter pylori and stomach cancer, hepatitis B and liver cancer: these are well-known examples in modern medicine, but the associations are ancient. Researchers studying pathogen genomes from ancient African populations have noted that human-pathogen coevolution has shaped cancer risk over deep timescales, and understanding these dynamics is essential for forecasting how emerging infectious diseases might influence cancer patterns in the future.23PubMed Central. Ancient oncogenesis, infection and human evolution
The fraction of human cancers attributable to infectious agents is substantial, with global estimates typically ranging from about 15% to 20%. In regions with high rates of chronic infection, the proportion is even higher. These cancers are natural in the fullest sense: they result from coevolutionary arms races between host and pathogen that have played out over millions of years. The pathogens did not “intend” to cause cancer. Rather, the molecular tricks they use to persist inside host cells, such as disabling tumor suppressors or hijacking cell growth pathways, happen to push cells toward malignancy as a collateral effect. Vaccination and treatment of these infections can prevent the cancers, but the underlying biology is as old as the host-pathogen relationship itself.